Toll Free: 1-888-928-9744

Flamel Technologies S.A. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Flamel Technologies S.A. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Flamel Technologies S.A. - Product Pipeline Review - 2014', provides an overview of the Flamel Technologies S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Flamel Technologies S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Flamel Technologies S.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Flamel Technologies S.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Flamel Technologies S.A.'s pipeline products

Reasons to buy

- Evaluate Flamel Technologies S.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Flamel Technologies S.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Flamel Technologies S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Flamel Technologies S.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Flamel Technologies S.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Flamel Technologies S.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Flamel Technologies S.A. Snapshot 5
Flamel Technologies S.A. Overview 5
Key Information 5
Key Facts 5
Flamel Technologies S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Flamel Technologies S.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Flamel Technologies S.A. - Pipeline Products Glance 12
Flamel Technologies S.A. - Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
Flamel Technologies S.A. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Flamel Technologies S.A. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Flamel Technologies S.A. - Drug Profiles 15
aldesleukin biobetter 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
FT-105 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Drug for Cardiovascular Disorders 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
GLP-1 biobetter 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Proteins for Undisclosed Indication 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecules for Undisclosed Indication 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
somatropin biobetter 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
tigecycline biobetter 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Drug for Pain 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Drug for Respiratory Disorders 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Flamel Technologies S.A. - Pipeline Analysis 25
Flamel Technologies S.A. - Pipeline Products by Target 25
Flamel Technologies S.A. - Pipeline Products by Route of Administration 26
Flamel Technologies S.A. - Pipeline Products by Molecule Type 27
Flamel Technologies S.A. - Pipeline Products by Mechanism of Action 28
Flamel Technologies S.A. - Dormant Projects 29
Flamel Technologies S.A. - Discontinued Pipeline Products 30
Discontinued Pipeline Product Profiles 30
interferon alfa-2b biobetter 30
interferon beta-1a biobetter 30
Flamel Technologies S.A. - Company Statement 31
Flamel Technologies S.A. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Flamel Technologies S.A. - Key Manufacturing Facilities 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37
List of Tables
Flamel Technologies S.A., Key Information 5
Flamel Technologies S.A., Key Facts 5
Flamel Technologies S.A. - Pipeline by Indication, 2014 7
Flamel Technologies S.A. - Pipeline by Stage of Development, 2014 8
Flamel Technologies S.A. - Monotherapy Products in Pipeline, 2014 9
Flamel Technologies S.A. - Partnered Products in Pipeline, 2014 10
Flamel Technologies S.A. - Partnered Products/ Combination Treatment Modalities, 2014 11
Flamel Technologies S.A. - Phase I, 2014 12
Flamel Technologies S.A. - Preclinical, 2014 13
Flamel Technologies S.A. - Unknown, 2014 14
Flamel Technologies S.A. - Pipeline by Target, 2014 25
Flamel Technologies S.A. - Pipeline by Route of Administration, 2014 26
Flamel Technologies S.A. - Pipeline by Molecule Type, 2014 27
Flamel Technologies S.A. - Pipeline Products by Mechanism of Action, 2014 28
Flamel Technologies S.A. - Dormant Developmental Projects,2014 29
Flamel Technologies S.A. - Discontinued Pipeline Products, 2014 30
Flamel Technologies S.A., Subsidiaries 34
Flamel Technologies S.A., Key Manufacturing Facilities 35 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify